Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
ROLE SUMMARY This position is a senior member of an 8-10 person team focused on creating or sourcing molecular assays to be used as diagnostic tests supporting vaccine development. The role includes
-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. POSITION SUMMARY As a Senior Scientist in the Molecular
-
discoveries in cancer research into the best medicines imaginable for patients. Pfizer's ORU in La Jolla, California, is seeking a Postdoctoral candidate (PhD) forthe Oncogene & Cancer Vulnerabilities (O&CV
-
oncology, the rapid development and deployment of increasingly sophisticated molecular assays has created an unprecedented scale of biomarker data for patients in clinical trials. This data represents
-
therapeutic approaches to treat neurodegenerative diseases Establish in vitro neuronal cell models to identify and evaluate targets using genetic and pharmacological approaches. Employ a variety of molecular
-
utilize cutting-edge chemical and biological tools to support our pre-clinical drug discovery programs. We are seeking an experienced cell and molecular biologist to contribute to the success
-
conformational analyses to establish molecular solution conformations to drive lead compound optimizations. Contribute to the development of new technology in ATCM such as microscale high-throughput NMR, high
-
for clinical molecular assays to support vaccine development and clinical studies. Complete required documentation for laboratory work involving assays. Execute qualifications/validations of new instruments and
-
, and other functional assays from human and animal models to evaluate immunogenicity of vaccine candidates. Establish robust reverse genetic system for recombinant virus generation. Develop new
-
system against cancer cells. The Chemoproteomics Team plays a vital role in this mission through enabling the discovery and molecular understanding of small-molecule therapeutics. We are seeking a